Marcus New - 01 Apr 2026 Form 3 Insider Report for HIVE Digital Technologies Ltd. (HIVE)

Reporting relationship: Director
Issuer ticker: HIVE
Reported as of: 01 Apr 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 01 Apr 2026, 14:02:14 UTC
Next SEC filing: 01 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Jonathan Gardner, by POA from Reporting Person

Key filing fact

Marcus New filed Form 3 for HIVE Digital Technologies Ltd. (HIVE) on 01 Apr 2026.

Key facts

This page summarizes Marcus New's Form 3 filing for HIVE Digital Technologies Ltd. (HIVE).
0 reported transactions and 11 derivative rows are listed below.
Accepted by SEC: 01 Apr 2026, 14:02.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001082331 Primary reporting owner

NEW MARCUS

Relationship: Director
Address: 7900 CALLAGHAN ROAD, SUITE 128, SAN ANTONIO
Signature: /s/ Jonathan Gardner, by POA from Reporting Person
Signature date: 01 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HIVE holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 6,000
Date: 01 Apr 2026
Ownership: Direct

HIVE holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 70,000
Date: 01 Apr 2026
Ownership: By ROI Capital Ltd.
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HIVE holding Derivative

Options (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 50,000
Exercise price: $7.17
Footnotes: F2, F3

HIVE holding Derivative

Options (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 400,000
Exercise price: $2.22
Footnotes: F4, F5

HIVE holding Derivative

Options (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price: $1.04
Footnotes: F6, F7

HIVE holding Derivative

Options (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 20,000
Exercise price: $4.92
Footnotes: F8, F9

HIVE holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Apr 2026
Ownership: By ROI Capital Ltd.
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price: $0.000000
Footnotes: F1, F10

HIVE holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Apr 2026
Ownership: By ROI Capital Ltd.
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price: $0.000000
Footnotes: F1, F11

HIVE holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Apr 2026
Ownership: By ROI Capital Ltd.
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price: $0.000000
Footnotes: F1, F12

HIVE holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Apr 2026
Ownership: By ROI Capital Ltd.
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price: $0.000000
Footnotes: F1, F13

HIVE holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Apr 2026
Ownership: By ROI Capital Ltd.
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price: $0.000000
Footnotes: F1, F14

HIVE holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Apr 2026
Ownership: By ROI Capital Ltd.
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price: $0.000000
Footnotes: F1, F15

HIVE holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Apr 2026
Ownership: By ROI Capital Ltd.
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price: $0.000000
Footnotes: F1, F16

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 16 footnotes

Footnote F1

These securities are directly held by ROI Capital Ltd. ("ROI"). The New Family Trust (the "Trust") is the sole shareholder of ROI. Mr. New is a trustee of the Trust.

Footnote F2

These options were granted on March 26, 2018 and are fully vested as of the date hereof.

Footnote F3

Represents an exercise price of $10.00 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.3939 reported by the Bank of Canada on March 31, 2026.

Footnote F4

These options were granted on September 18, 2018 and are fully vested as of the date hereof.

Footnote F5

Represents an exercise price of $3.10 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.3939 reported by the Bank of Canada on March 31, 2026.

Footnote F6

These options were granted on February 10, 2020 and are fully vested as of the date hereof.

Footnote F7

Represents an exercise price of $1.45 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.3939 reported by the Bank of Canada on March 31, 2026.

Footnote F8

These options were granted on July 6, 2023 and are fully vested as of the date hereof.

Footnote F9

Represents an exercise price of $6.86 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.3939 reported by the Bank of Canada on March 31, 2026.

Footnote F10

Each Restricted Stock Unit ("RSU") represents the right to receive, at settlement, one share of common stock. The RSUs were issued on July 18, 2024 and are fully vested as of the date hereof.

Footnote F11

Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on November 5, 2024 and 62,750 have vested, with the remaining 37,500 vesting in 3 equal installments on May 5, 2026, August 5, 2026, and November 5, 2026.

Footnote F12

Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on February 14, 2025 and are fully vested as of the date hereof.

Footnote F13

Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on April 17, 2025 and will vest in one installment on April 17, 2026.

Footnote F14

Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on July 8, 2025 and will vest in one installment on July 8, 2026.

Footnote F15

Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on October 31, 2025 and will vest in one installment on October 31, 2026.

Footnote F16

Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on March 16, 2026 and will vest in one installment on March 16, 2027.

SEC remarks

The Board of Directors of HIVE Digital Technologies Ltd. (the "Company" ) has determined that the Company no longer qualifies as a foreign private issuer. As a result, effective April 1, 2026, the Company is required to comply with the reporting requirements and use the filing forms applicable to U.S. public companies under U.S. securities laws, including reports required under Section 16 of the U.S. Securities Exchange Act of 1934, as amended. The Reporting Person is filing this Form 3 in connection with this transition. Exhibit 24 Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .